
Last update at 2026-06-24T15:38:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Pablo Perversi to Join METTLER TOLEDO Board of Directors
Mon 04 Aug 25, 08:30 PM1 Unpopular Stock that Deserves a Second Chance and 2 to Be Wary Of
Mon 19 May 25, 04:40 AMMettler-Toledo International (NYSE:MTD) Reports Earnings Decline in Q1 2025
Tue 13 May 25, 11:33 PM1 Healthcare Stock to Consider Right Now and 2 to Brush Off
Fri 09 May 25, 04:35 AMMTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise
Mon 05 May 25, 02:33 PMWhat To Expect From Waters Corporation’s (WAT) Q1 Earnings
Mon 05 May 25, 07:13 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 1070.59M | 949.36M | 748.74M | 681.39M | 651.86M |
| Minority interest | - | - | - | - | - |
| Net income | 872.50M | 768.99M | 602.74M | 561.11M | 512.61M |
| Selling general administrative | 938.46M | 943.98M | 820.22M | 819.18M | 812.80M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 2308.04M | 2171.55M | 1801.03M | 1741.21M | 1684.38M |
| Reconciled depreciation | 113.02M | 108.06M | 98.71M | 88.68M | 84.69M |
| Ebit | 1135.54M | 997.84M | 797.88M | 734.57M | 704.79M |
| Ebitda | 1248.56M | 1105.90M | 896.58M | 823.25M | 789.48M |
| Depreciation and amortization | 113.02M | 108.06M | 98.71M | 88.68M | 84.69M |
| Non operating income net other | 9.32M | 3.11M | 13.83M | 6.18M | 21.81M |
| Operating income | 1135.54M | 997.84M | 797.88M | 734.57M | 682.98M |
| Other operating expenses | 2793.49M | 2723.19M | 2301.13M | 2280.26M | 2252.61M |
| Interest expense | 55.39M | 43.24M | 38.62M | 37.41M | 34.51M |
| Tax provision | 198.09M | 180.38M | 146.00M | 120.28M | 139.25M |
| Interest income | - | - | - | - | - |
| Net interest income | -55.39200M | -43.24200M | -38.61600M | -37.41100M | -34.51100M |
| Extraordinary items | - | - | - | 0.00000M | -3.59700M |
| Non recurring | 9.56M | 5.24M | 10.52M | 15.76M | 18.42M |
| Other items | - | - | - | - | - |
| Income tax expense | 198.09M | 180.38M | 146.00M | 120.28M | 139.25M |
| Total revenue | 3919.71M | 3717.93M | 3085.18M | 3008.65M | 2935.59M |
| Total operating expenses | 1181.82M | 1176.82M | 1016.99M | 1012.82M | 1001.40M |
| Cost of revenue | 1611.67M | 1546.38M | 1284.15M | 1267.44M | 1251.21M |
| Total other income expense net | -64.94800M | -48.48100M | -49.13200M | -53.17100M | 3.39M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 872.50M | 768.99M | 602.74M | 561.11M | 512.61M |
| Net income applicable to common shares | 872.50M | 768.99M | 602.74M | 561.11M | 512.61M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 3492.39M | 3326.80M | 2814.55M | 2789.32M | 2618.85M |
| Intangible assets | 306.05M | 307.45M | 196.78M | 206.24M | 217.31M |
| Earning assets | - | - | - | - | - |
| Other current assets | 128.11M | 108.92M | 71.23M | 61.32M | 63.40M |
| Total liab | 3467.60M | 3155.38M | 2531.87M | 2368.54M | 2028.78M |
| Total stockholder equity | 24.79M | 171.42M | 282.68M | 420.78M | 590.06M |
| Deferred long term liab | 111.36M | 62.23M | 34.45M | 45.27M | 48.82M |
| Other current liab | 596.38M | 579.85M | 465.10M | 390.56M | 382.74M |
| Common stock | 0.45M | 0.45M | 0.45M | 0.45M | 0.45M |
| Capital stock | 0.45M | 0.45M | 0.45M | 0.45M | 0.45M |
| Retained earnings | 6726.87M | 5859.27M | 5095.60M | 4499.29M | 3941.92M |
| Other liab | 324.50M | 428.03M | 407.37M | 316.19M | 309.30M |
| Good will | 660.17M | 648.62M | 550.27M | 535.98M | 534.78M |
| Other assets | 372.48M | 302.00M | 211.72M | 101.48M | 102.83M |
| Cash | 95.97M | 98.56M | 94.25M | 207.78M | 178.11M |
| Cash and equivalents | 95.97M | 98.56M | 94.25M | 207.78M | 178.11M |
| Total current liabilities | 1147.73M | 1146.54M | 840.33M | 754.51M | 734.43M |
| Current deferred revenue | 192.76M | 192.65M | 149.11M | 122.49M | 105.38M |
| Net debt | 1918.57M | 1583.38M | 1240.24M | 1083.43M | 856.58M |
| Short term debt | 106.05M | 101.13M | 50.32M | 55.87M | 49.67M |
| Short long term debt | 106.05M | 101.13M | 50.32M | 55.87M | 49.67M |
| Short long term debt total | 2014.53M | 1681.94M | 1334.49M | 1291.22M | 1034.69M |
| Other stockholder equity | -6475.28800M | -5433.07500M | -4478.44400M | -3755.28300M | -3050.30100M |
| Property plant equipment | 778.60M | 799.37M | 798.87M | 748.66M | 717.53M |
| Total current assets | 1375.09M | 1269.36M | 1056.90M | 1109.65M | 1045.86M |
| Long term investments | - | - | - | - | 0.55M |
| Net tangible assets | 24.79M | 171.42M | 282.68M | -321.44100M | -162.02500M |
| Short term investments | - | - | - | - | - |
| Net receivables | 709.32M | 647.34M | 593.81M | 566.26M | 535.53M |
| Long term debt | 1908.48M | 1580.81M | 1284.17M | 1235.35M | 985.02M |
| Inventory | 441.69M | 414.54M | 297.61M | 274.29M | 268.82M |
| Accounts payable | 252.54M | 272.91M | 175.80M | 185.59M | 196.64M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -227.23300M | -255.22400M | -334.92500M | -323.67300M | -302.41400M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 0.45M | 0.45M | 0.45M | 0.45M | 0.45M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 6726.87M | 5859.27M | 5095.60M | 4499.29M | 3941.92M |
| Treasury stock | -7325.65600M | -6259.04900M | -5283.58400M | -4539.15400M | -3814.60400M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 345.40M | 302.00M | 211.72M | 188.80M | 103.37M |
| Deferred long term asset charges | - | - | - | 36.98M | 35.07M |
| Non current assets total | 2117.31M | 2057.44M | 1757.64M | 1679.67M | 1572.99M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | 1908.48M | 1580.81M | 1284.17M | 1235.35M | 985.02M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -139.39500M | -314.10800M | -100.36000M | -99.08300M | -138.94400M |
| Change to liabilities | -29.56400M | 194.62M | 32.84M | -23.78200M | 5.57M |
| Total cashflows from investing activities | -139.39500M | -314.10800M | -100.36000M | -99.08300M | -138.94400M |
| Net borrowings | 359.86M | 391.97M | 5.17M | 258.30M | 62.38M |
| Total cash from financing activities | -716.03900M | -590.54900M | -743.90800M | -477.36800M | -388.02200M |
| Change to operating activities | -87.86000M | 4.39M | 19.75M | -5.72000M | -25.95000M |
| Net income | 872.50M | 768.99M | 602.74M | 561.11M | 512.61M |
| Change in cash | -2.59800M | 4.31M | -113.53100M | 29.68M | 29.42M |
| Begin period cash flow | 98.56M | 94.25M | 207.78M | 178.11M | 148.69M |
| End period cash flow | 95.97M | 98.56M | 94.25M | 207.78M | 178.11M |
| Total cash from operating activities | 859.07M | 908.83M | 724.70M | 603.45M | 565.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 113.02M | 108.06M | 98.71M | 88.68M | 84.69M |
| Other cashflows from investing activities | -18.15400M | -206.52800M | -7.86600M | -1.74200M | 3.78M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -43.39200M | -118.71800M | -3.83600M | -4.60300M | -21.19500M |
| Change to account receivables | -83.41700M | -66.46800M | -4.49500M | -31.40800M | -19.54000M |
| Sale purchase of stock | -1099.99800M | -999.99800M | -774.99800M | -774.99900M | -474.99900M |
| Other cashflows from financing activities | 2317.60M | 2444.99M | 1514.96M | 1474.41M | 963.30M |
| Change to netincome | 19.66M | 26.82M | 16.29M | 18.42M | -1.35200M |
| Capital expenditures | 121.24M | 107.58M | 92.49M | 97.34M | 142.73M |
| Change receivables | -83.41700M | -66.46800M | -4.49500M | -31.40800M | -19.54000M |
| Cash flows other operating | 10.25M | -4.47700M | -17.54700M | -4.96500M | 4.22M |
| Exchange rate changes | - | 0.14M | 6.04M | 2.68M | -8.61600M |
| Cash and cash equivalents changes | 3.63M | 4.31M | -113.53100M | 29.68M | 29.42M |
| Change in working capital | -172.63600M | 4.39M | 19.75M | -60.12800M | -34.54200M |
| Stock based compensation | 19.66M | 19.59M | 18.69M | 18.29M | 17.58M |
| Other non cash items | - | 7.23M | -2.39900M | 0.13M | -21.23300M |
| Free cash flow | 737.83M | 801.25M | 632.21M | 506.11M | 422.28M |
Sector: Healthcare Industry: Diagnostics & Research
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International Inc |
52.34 4.52% | 1208.97 | 30.96 | 30.03 | 6.70 | 3980.99 | 7.10 | 22.05 |
| TMO Thermo Fisher Scientific Inc |
17.48 3.73% | 486.83 | 34.71 | 23.87 | 4.62 | 4.43 | 5.29 | 20.89 |
| DHR Danaher Corporation |
8.68 4.85% | 187.65 | 29.09 | 28.01 | 5.67 | 3.20 | 6.00 | 19.09 |
| A Agilent Technologies Inc |
4.68 3.70% | 131.35 | 34.36 | 26.39 | 6.59 | 7.14 | 6.78 | 23.56 |
| IDXX IDEXX Laboratories Inc |
11.15 2.06% | 552.46 | 49.99 | 45.66 | 11.29 | 27.85 | 11.46 | 34.46 |
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labelling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
1900 Polaris Parkway, Columbus, OH, United States, 43240
| Name | Title | Year Born |
|---|---|---|
| Mr. Patrick K. Kaltenbach | Pres & CEO | 1963 |
| Mr. Shawn P. Vadala | Chief Financial Officer | 1969 |
| Mr. Marc de La Gueronniere | Head of European & North American Market Organizations | 1964 |
| Mr. Peter Aggersbjerg | Head of Divisions | 1968 |
| Mr. Gerhard Keller | Head of Process Analytics | 1968 |
| Ms. Mary T. Finnegan | Head of Investor Relations & Treasurer | NA |
| Ms. Michelle M. Roe | Gen. Counsel & Sec. | 1971 |
| Mr. Christian Magloth | Head of HR | 1966 |
| Mr. Richard Wong | Head of Asia/Pacific Market Organizations | NA |
| Mr. Oliver Wittorf | Head of Supply Chain & IT | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.